KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days £260.00 £312.00 Friday, 26th Apr 2024 HCM.L stock ended at £290.00. This is 4.61% less than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 8.75% from a day low at £286.90 to a day high of £312.00.
90 days £190.40 £312.00
52 weeks £173.60 £338.00

Historical Hutchison China Meditech Ltd ADR (Sponsored) prices

Date Open High Low Close Volume
Apr 26, 2024 £304.00 £312.00 £286.90 £290.00 85 819
Apr 25, 2024 £309.00 £310.00 £300.00 £304.00 216 468
Apr 24, 2024 £299.00 £303.00 £295.52 £296.00 53 971
Apr 23, 2024 £275.00 £295.00 £271.00 £290.00 261 519
Apr 22, 2024 £262.00 £280.00 £262.00 £276.00 259 307
Apr 19, 2024 £266.00 £271.80 £261.00 £270.00 9 140
Apr 18, 2024 £263.00 £271.00 £260.00 £271.00 13 846
Apr 17, 2024 £265.00 £273.60 £265.00 £270.00 1 549
Apr 16, 2024 £280.00 £280.00 £267.00 £268.00 102 901
Apr 15, 2024 £289.99 £291.00 £281.20 £287.00 31 690
Apr 12, 2024 £293.40 £294.00 £289.50 £290.00 75 759
Apr 11, 2024 £289.00 £296.00 £287.00 £293.00 21 157
Apr 10, 2024 £282.00 £289.00 £275.00 £282.00 37 795
Apr 09, 2024 £278.00 £294.99 £277.00 £278.00 189 215
Apr 08, 2024 £269.00 £273.00 £260.00 £270.00 24 078
Apr 05, 2024 £261.00 £273.00 £260.87 £261.00 24 701
Apr 04, 2024 £266.00 £270.60 £266.00 £267.00 17 761
Apr 03, 2024 £275.00 £275.00 £269.00 £270.00 75 012
Apr 02, 2024 £267.50 £267.50 £267.50 £267.50 0
Mar 28, 2024 £266.50 £273.00 £261.51 £267.50 18 840
Mar 27, 2024 £271.50 £272.50 £261.91 £264.50 60 931
Mar 26, 2024 £260.26 £269.50 £256.50 £264.00 36 165
Mar 25, 2024 £271.50 £271.50 £264.50 £267.00 54 909
Mar 22, 2024 £255.50 £266.04 £254.45 £262.00 73 487
Mar 21, 2024 £272.50 £277.00 £265.00 £275.50 59 696
Click to get the best stock tips daily for free!

About Hutchison China Meditech Ltd ADR (Sponsored)

Hutchison China Meditech Ltd ADR (Sponsored) HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and renal cell carcinoma, colorectal cancer (CRC), and gastric cancer (GC); and Fruquintinib, an inhibitor for ... HCM.L Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT